Evidence map›Paper›PMID 30704779›Full record

ArticleDiagnostic microbiology and infectious disease2019

Field evaluation of a dual rapid Human Immunodeficiency Virus and treponemal syphilis rapid test in community-based clinics in Los Angeles and New York.

Chrysovalantis Stafylis, Claire C Bristow, Lauren J Natoli, Katheryn R Salow, Emma Davidson, Yancy Granados, Mark McGrath, Jeffrey D Klausner

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Diagnostic microbiology and infectious disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chrysovalantis StafylisDavid Geffen School of Medicine at UCLA, 10920 Wilshire Blvd, Los Angeles, CA, 90024, USA. Electronic address: chrstafylis@outlook.com.
Claire C BristowDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Dr 0507, La Jolla, CA 92093, USA.
Lauren J NatoliAIDS Healthcare Foundation, 1811 N Western Ave, Los Angeles, CA, 90027, USA.
Katheryn R SalowAIDS Healthcare Foundation, 1811 N Western Ave, Los Angeles, CA, 90027, USA.
Emma DavidsonAIDS Healthcare Foundation, 1811 N Western Ave, Los Angeles, CA, 90027, USA.
Yancy GranadosAIDS Healthcare Foundation, 1811 N Western Ave, Los Angeles, CA, 90027, USA.
Mark McGrathAIDS Healthcare Foundation, 1811 N Western Ave, Los Angeles, CA, 90027, USA.
Jeffrey D KlausnerDavid Geffen School of Medicine at UCLA, 10920 Wilshire Blvd, Los Angeles, CA, 90024, USA.
AIDS Healthcare Foundation · USUniversity of California, Los Angeles · USUniversity of California, San Diego · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHEN, IRVIN S.Y. · 1991 to 2018
$39.9M
HOPE Training GrantT32AI007384 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sara Gianella Weibel, Scott L Letendre · 1990 to 2026
$9.7M
Molecular epidemiology of HIV and Neisseria gonorrhoeae in the context of drug resistanceK01AI136725 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BRISTOW, CLAIRE C · 2018 to 2022
$689k
NCATS NIH HHS UL1 TR001442NIAID NIH HHS K01 AI136725NIAID NIH HHS P30 AI028697NIAID NIH HHS P30 AI036214NIAID NIH HHS T32 AI007384NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

introductionDual human immunodeficiency virus/syphilis rapid diagnostic devices can play an important role in prevention efforts. The field performance of the INSTI Multiplex HIV-1/HIV-2/Syphilis Antibody Test (Multiplex) was evaluated.

methodsFingerstick whole blood was tested using the rapid test. A fourth-generation HIV laboratory assay and treponemal-specific laboratory assays were used as reference. Rapid plasma reagin (RPR) was used to stratify treponemal results. Sensitivity and specificity were calculated.

resultsOverall, 274 patients participated. Sensitivity of the Multiplex for detection of HIV was 98.8% (95% CI, 93.4-100%), and specificity was 100% (95% CI, 98.1-100%). Sensitivity for detection of syphilis antibodies was 56.8% (95% CI, 44.7-68.2%), and specificity was 98.5% (95% CI, 95.7-99.7%). Sensitivity for treponemal antibodies improved with increasing RPR and was 100% (95% CI, 78.2-100%) among samples with RPR titers ≥1:8.

conclusionsThe Multiplex showed excellent performance for detection of HIV antibodies and increasing sensitivity for detection of treponemal antibody with increasing RPR titer.

Indexed as

Diagnostic Tests, RoutineHIV InfectionsHumansImmunoassayLos AngelesNew YorkSensitivity and SpecificitySyphilisTime FactorsDiagnosisDual testHIVRapid testTreponema pallidum

Identifiers

PMID30704779
PMCPMC7643540
OpenAlexW2896321680

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.